Targeted Therapies for Pediatric Brain Injury

Dr. Manideep Chavali studies cell pathways to develop targeted therapies for chronic childhood diseases like brain injury.

Targeted Therapies for Pediatric Brain Injury

Image: news.ohsu.edu

Dr. Manideep Chavali, Ph.D., is researching how a deeper understanding of cellular pathways could lead to targeted therapies for pediatric brain injury and other chronic childhood diseases. His work focuses on the molecular mechanisms underlying brain development and injury repair.

According to his research profile at the University of California, San Francisco, Chavali aims to identify specific cell signaling pathways that could be modulated to promote recovery after brain injury in children. This approach represents a shift from generalized treatments to precision medicine tailored to individual cellular responses.

The research is still in early stages, with no clinical trials yet announced. However, Chavali's team has published findings on how certain pathways influence neural stem cell behavior, which could inform future therapies. The work is funded by the National Institutes of Health.

❓ Frequently Asked Questions

What is the main goal of Dr. Chavali's research?

To develop targeted therapies for pediatric brain injury by understanding cellular pathways involved in brain development and repair.

Is this research currently in clinical trials?

No, the research is in early stages and no clinical trials have been announced yet.

Where is Dr. Chavali based?

He is based at the University of California, San Francisco, and his work is funded by the National Institutes of Health.

📰 Source:
news.ohsu.edu →
Share: